Suchergebnisse

Intro -- Contents -- Acknowledgments -- Introduction and Explanation of Scope -- Part I What Is Money Laundering? -- Chapter 1 The Basic Money Laundering Arrangement -- Chapter 2 The Andean Cocaine Business -- Chapter 3 Foreign Exchange Black Markets in Latin America -- Chapter 4 A Recent History of U.S. Money Laundering Regulations, 1970- 98 -- Part II How to Launder Millions -- Chapter 5 Early Cases, 1970s and Early 1980s -- Chapter 6 La Mina, 1985-88 -- Chapter 7 General Noriega and Panama, 1981- 89 -- Chapter 8 The Bank of Crooks and Criminals, Inc., 1988-90 -- Chapter 9 The Santacruz- Londono Organization, 1988- 90 -- Chapter 10 Stephen Saccoccia, 1988-91 -- Chapter 11 Retail Money Laundries, 1990-95 -- Chapter 12 The Raul Salinas Saga, 1992-94 -- Chapter 13 The Mexican Connection: Operation Casablanca, 1995-99 -- Part III Economic Issues and Lessons -- Chapter 14 Mexico's Black Market in Foreign Exchange and Its Relation to Narcotics Money Laundering -- Chapter 15 The Colombian Connection -- Chapter 16 How Should Banks Deal with Money Laundering? -- Chapter 17 Conclusions and Government Policy Recommendations -- Appendix The Forty Recommendations of The Financial Action Task Force on Money Laundering -- Selected Bibliography -- Index.

"Where my health is concerned, cost is no ob ject." The reply of the penniless man to an expensive spe cialist reflects a moral question. Should the costs of health services be a significant consideration in deciding upon gov ernmental health policies and programs? The answer in my opinion is yes. Costs ought to be used in deciding the level of health activities versus other social goods and services, and in planning which health programs to support. The truly moral problem is not to distinguish between good and evil but rather to select appropriately among alternative goods. After argu ing that consideration of cost is a moral imperative, the useful ness of cost-benefit analysis in framing the right questions and in improving the chances of moving in directions of social improvement is urged, and some limitations are noted. Fi nally, examples of the use of cost-effectiveness analysis in studying problems of disease control and maternal and child health are given.

The maxim 'Where my health is concerned, cost is no object' is examined. The reply of the penniless man to an expensive specialist reflects a moral question. Should the costs of health services be a signif consideration in deciding upon gov'al health policies & programs? The answer given is yes. Costs ought to be used in deciding the level of health activities vs other soc goods & services, & in planning which health programs to support. The truly moral problem is not to distinguish between good & evil but rather to select appropriately among alternative goods. After arguing that consideration of cost is a moral imperative, the usefulness of cost-benefit analysis in framing the right questions & in improving the chances of moving in directions of soc improvement is urged, & some limitations are noted. Finally, examples of the use of cost-effectiveness analysis in studying problems of disease control & maternal & child health are given. Modified HA.

[2], 62 p. ; T.p. is engraved. ; Place of publication from Wing. ; Annotation on Thomason copy: "July 7th 1647". ; Imperfect: heavy foxing in places, affecting text. ; Reproduction of the original in the British Library.